Harbour BioMed
↗Shanghai, China
Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel antibody therapeutics in the areas of immunology and oncology. The company leverages its proprietary Harbour Mice® platforms (H2L2 and HCAb) to generate fully human monoclonal and bispecific antibodies. These platforms are also utilized by its subsidiary, Nona Biosciences, to provide integrated antibody discovery solutions to global partners.
Headquartered in Shanghai with major R&D centers in Boston and Rotterdam, Harbour BioMed has established a robust pipeline of over 10 clinical-stage assets. The company is known for its high-value strategic collaborations with industry leaders such as AstraZeneca, Bristol Myers Squibb, and Pfizer, focusing on next-generation modalities including antibody-drug conjugates (ADCs) and T-cell engagers.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$100M-$250M
Founded:2016
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$532.8M
Investors:AstraZeneca, Advantech Capital, GIC, Hillhouse Capital, Hudson Bay Capital, OrbiMed
STOCK
Exchange:HKEX
Ticker:02142
Market Cap:$1.25B
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3 (Batoclimab)
Modalities:mAb, Bispecific Antibody, ADC, HCAb, T-cell Engager
Active Trials:12
Trial Phases:Phase 1: 6 | Phase 2: 4 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Nona Biosciences, Harbour Antibodies BV, Élancé Therapeutics
Key Partnerships:AstraZeneca (HBM7022/AZD5863 licensing), Bristol Myers Squibb (Multi-specific antibody discovery), Pfizer (Nona Biosciences collaboration), Moderna (Nona Biosciences collaboration), Otsuka Pharmaceutical (HBM7020 licensing), Insilico Medicine (AI-driven antibody discovery)
COMPETITION
Position:Emerging
Competitors:Beigene, Zai Lab, Innovent Biologics, Argenx, Genmab
LEADERSHIP
Key Executives:
Jingsong Wang - Founder, Chairman & CEO
Yajie Li - Chief Medical Officer
Scientific Founders:Jingsong Wang
Board Members:Jingsong Wang, Xiaoping Ye, Wei Zhou
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Harbour BioMed. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.